dc.creator | Cabral, Caroline Almeida | |
dc.creator | Rolim Neto, Modesto Leite | |
dc.creator | Teixeira, Saulo Araujo | |
dc.date.accessioned | 2013-10-24T16:15:23Z | |
dc.date.accessioned | 2018-07-04T16:00:28Z | |
dc.date.available | 2013-10-24T16:15:23Z | |
dc.date.available | 2018-07-04T16:00:28Z | |
dc.date.created | 2013-10-24T16:15:23Z | |
dc.date.issued | 2012 | |
dc.identifier | HEALTHMED, SARAJEVO, v. 6, n. 9, supl., Part 1-2, pp. 3020-3022, JUL-DEC, 2012 | |
dc.identifier | 1840-2291 | |
dc.identifier | http://www.producao.usp.br/handle/BDPI/35860 | |
dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/1630376 | |
dc.description.abstract | Introduction: Persistently high glycemic levels are extremely harmful to the organism and can lead patients to several complications of diabetes mellitus. Glycated hemoglobin represents the glycemic levels for what patient is chronically exposed. Methods: Two virtual databases were surveyed in two languages: Portuguese and English. 12 articles were selected and reviewed. Results and discussion: The HbA1c is used since 1958 in the assessment of glycemic control in diabetic patients. It is formed by a chemical reaction between hemoglobin A and acarbohydrate. Each percentage point of glycated hemoglobin represents approximately 35mg/dL in patient's averageglycemia. Conclusion: The glycated hemoglobin should be measured at least twice per year in patients with diabetes in general. In case of change of hypoglycemic therapy, this frequency should be doubled. | |
dc.language | eng | |
dc.publisher | DRUNPP-SARAJEVO | |
dc.publisher | SARAJEVO | |
dc.relation | HEALTHMED | |
dc.rights | Copyright DRUNPP-SARAJEVO | |
dc.rights | closedAccess | |
dc.subject | GLYCATED HEMOGLOBIN | |
dc.subject | DIABETES MELLITUS | |
dc.subject | COMPLICATIONS | |
dc.subject | GLYCEMIA | |
dc.title | Role of glycated hemoglobin in the care of diabetes mellitus | |
dc.type | Artículos de revistas | |